Currently, there are 377.37M common shares owned by the public and among those 356.77M shares have been available to trade.
Insiders at the company have transacted a total of 26 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 2 of these insider trades were purchases, accounting for 71,009 shares. Insider sales of the common stock occurred on 24 occasions, with total insider shares sold totaling 36,384,594 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of 1.14% and 44.77% over the past three months. VRT shares are trading 29.13% year to date (YTD), with the 12-month market performance up to 286.90% higher. It has a 12-month low price of $11.95 and touched a high of $65.56 over the same period. VRT has an average intraday trading volume of 6.28 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.41%, 18.23%, and 68.54% respectively.
Institutional ownership of Vertiv Holdings Co (NYSE: VRT) shares accounts for 88.67% of the company’s 377.37M shares outstanding.
It has a market capitalization of $23.66B and a beta (3y monthly) value of 1.55. The stock’s trailing 12-month PE ratio is 95.22, while the earnings-per-share (ttm) stands at $0.65. The company has a PEG of 1.29 and a Quick Ratio of 1.28 with the debt-to-equity ratio at 1.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.60% over the week and 4.39% over the month.
Analysts forecast that Vertiv Holdings Co (VRT) will achieve an EPS of $Vaxart, Inc. – Common Stock for the current quarter, $1.23 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Vertex Pharmaceuticals Incorpor while analysts give the company a high EPS estimate of $Vertiv Holdings, LLC. Comparatively, EPS for the current quarter was $Vanguard Total World Stock Inde a year ago. Earnings per share for the fiscal year are expected to increase by 230.40%, and 27.77% over the next financial year.
Looking at the support for the VRT, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on August 02, 2023, with the firm’s price target at $40. Cowen was of a view on October 27, 2022 that the stock is Outperform, while JP Morgan gave the stock Overweight rating on April 01, 2022, issuing a price target of $29- $18. Cowen on their part issued Market Perform rating on February 24, 2022.
